Company Overview of Staidson (Beijing) Biopharmaceuticals Co., Ltd.
Staidson (Beijing) Biopharmaceuticals Co., Ltd. engages in the research, development, production, and sale of biological products. Its products include Su peptide Health, an injection of mouse nerve growth factor; and Shu Taiqing, Gliclazide, Nabumetone, and aspirin. The company offers its products in the form of tablets, powders, capsules, and injections. Staidson (Beijing) Biopharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.
Beijing Economic and Technological Development Zone
Sea Road No. 36
Founded in 2002
86 10 6751 9888
86 10 6751 9794
Key Executives for Staidson (Beijing) Biopharmaceuticals Co., Ltd.
Staidson (Beijing) Biopharmaceuticals Co., Ltd. does not have any Key Executives recorded.
Staidson (Beijing) Biopharmaceuticals Co., Ltd. Key Developments
Similar Private Companies By Industry
|Aleph Biological Co., Ltd.||Asia|
|Allist Pharmaceuticals, Inc.||Asia|
|Alpha Pharmaceutical Co.,Ltd. Jiangsu Province||Asia|
|Amerigen Pharmaceuticals Limited||Asia|
Recent Private Companies Transactions
July 18, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Staidson (Beijing) Biopharmaceuticals Co., Ltd., please visit www.staidson.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.